IRIS
MARONGIU, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.061
AS - Asia 1.360
SA - Sud America 963
EU - Europa 789
AF - Africa 51
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.980
BR - Brasile 829
SG - Singapore 632
IT - Italia 355
CN - Cina 250
HK - Hong Kong 217
DE - Germania 139
VN - Vietnam 66
FI - Finlandia 56
AR - Argentina 55
GB - Regno Unito 51
UA - Ucraina 30
CA - Canada 29
FR - Francia 29
MX - Messico 29
TR - Turchia 27
IN - India 25
RU - Federazione Russa 25
BD - Bangladesh 20
ZA - Sudafrica 18
IQ - Iraq 17
KR - Corea 17
NL - Olanda 17
EC - Ecuador 16
PL - Polonia 16
VE - Venezuela 16
CO - Colombia 15
SE - Svezia 13
AT - Austria 11
CZ - Repubblica Ceca 11
JP - Giappone 10
AZ - Azerbaigian 9
BE - Belgio 9
ES - Italia 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 7
IL - Israele 7
KE - Kenya 7
LT - Lituania 7
UY - Uruguay 7
BO - Bolivia 6
ID - Indonesia 6
JM - Giamaica 6
PY - Paraguay 6
PE - Perù 5
AU - Australia 4
KG - Kirghizistan 4
KZ - Kazakistan 4
MA - Marocco 4
SA - Arabia Saudita 4
TN - Tunisia 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
CR - Costa Rica 3
EG - Egitto 3
GH - Ghana 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
AL - Albania 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
IR - Iran 2
MY - Malesia 2
PH - Filippine 2
QA - Qatar 2
XK - ???statistics.table.value.countryCode.XK??? 2
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CD - Congo 1
CH - Svizzera 1
CY - Cipro 1
DZ - Algeria 1
GY - Guiana 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
LV - Lettonia 1
NE - Niger 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TG - Togo 1
TM - Turkmenistan 1
UG - Uganda 1
Totale 5.230
Salva come PNG Salva come JPEG
Città #
Dallas 1.198
Singapore 337
Hong Kong 213
Beijing 107
Ashburn 99
Chandler 78
Munich 71
São Paulo 55
Los Angeles 40
New York 40
Shanghai 39
Belo Horizonte 32
Boardman 32
Ho Chi Minh City 30
Cagliari 29
Rio de Janeiro 28
Turku 26
Helsinki 23
Milan 22
Sassari 19
Florence 18
West Jordan 18
Rome 17
Seoul 17
Brasília 16
Buenos Aires 15
Frankfurt am Main 14
Princeton 14
Warsaw 14
Recife 13
Alghero 12
Jacksonville 12
Johannesburg 12
Montreal 12
Nuremberg 12
Santa Clara 12
Brooklyn 11
Falkenstein 11
Manaus 11
Poplar 11
Campinas 10
Chicago 10
Düsseldorf 10
Guarulhos 10
London 10
Salvador 10
Stockholm 10
Ankara 9
Baku 9
Boston 9
Curitiba 9
Denver 9
Goiânia 9
Seattle 9
Tashkent 9
Tokyo 9
Atlanta 8
Brussels 8
Hanoi 8
Lauterbourg 8
Mexico City 8
Nova Iguaçu 8
Ribeirão Preto 8
Romola 8
Bologna 7
Brno 7
Chennai 7
Lappeenranta 7
Manchester 7
Orem 7
Wilmington 7
Ann Arbor 6
Anápolis 6
Baghdad 6
Columbus 6
Dearborn 6
Dhaka 6
Fortaleza 6
Guayaquil 6
Istanbul 6
Nairobi 6
Nanjing 6
Osasco 6
Pelotas 6
Santiago 6
Selargius 6
Shenzhen 6
The Dalles 6
Toronto 6
Trieste 6
Amsterdam 5
Campo Grande 5
Caxias do Sul 5
Conselheiro Lafaiete 5
Cuiabá 5
Hangzhou 5
Hortolândia 5
João Pessoa 5
Juiz de Fora 5
Kingston 5
Totale 3.218
Salva come PNG Salva come JPEG
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 317
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 291
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 157
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 154
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 134
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 133
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 131
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 127
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 123
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 118
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 117
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 117
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 113
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 113
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 108
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 105
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 103
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 100
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 95
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 95
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 92
Large Italian Multicenter Study on Prognostic Value of Baselines Variables in mCRPC Patients Treated with 223RaCl2: Ten Years of Clinical Experience 90
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 89
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 88
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 87
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 87
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 86
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 86
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 85
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 84
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 84
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 84
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 82
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 80
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? 79
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 79
Multi-centre data harmonisation applied to heart-to-mediastinum quantification in parkinsonism (ITA-MIBG): a cross-calibration phantom study with tube and bottle 76
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 74
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 73
The prognostic role of [18F]FDG PET/CT for suspected recurrence or monitoring systemic treatment in triplenegative breast cancer: preliminary results of the TRINE-PET trial. 70
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 70
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 70
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 69
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy 69
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 66
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 63
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 62
Radiomics Features from Positron Emission Tomography with [18F] Fluorodeoxyglucose Can Help Predict Cervical Nodal Status in Patients with Head and Neck Cancer 62
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 60
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 56
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 55
Radionuclide-based nanotechnologies in brain tumors: an updated overview 50
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 50
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of the TRINE-PET trial 48
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 47
Diagnostic Accuracy of DaTQUANT® Versus BasGanV2™ for 123I-Ioflupane Brain SPECT: A Machine Learning-Based Differentiation of Parkinson’s Disease and Essential Tremor 8
Artificial Intelligence in PET Imaging for Alzheimer’s Disease: A Narrative Review 8
The impact of [18F]FDG PET/CT in guiding the change of management of triple-negative breast cancer patients: a sub-analysis of the TRINE-PET trial 6
Totale 5.325
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.746
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.746
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 5 0 5 6 0 0
2021/202243 5 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/20252.126 44 48 121 96 79 100 106 321 664 313 124 110
2025/20262.531 179 832 610 480 393 37 0 0 0 0 0 0
Totale 5.325